Home › Tools › Dose plotter

Dose plotter

See how repeated doses rise, overlap and settle over the weeks, using published half-lives.

–

An estimate from published half-lives, not a blood test. It can't tell you how you'll feel or what to take. Reko does not suggest doses, and this is not medical advice.

How it works

Each dose gets its own rise-and-fall curve, and the line is the sum of them. Half-lives used: semaglutide about 7 days and tirzepatide about 5 days, from their U.S. labels. Retatrutide uses about 6 days, from less published data. Absorption times are the same published estimates the app uses.

The full explanation

In the app

Reko draws this from the doses you actually logged, with your weight and side effects beside it.

Sources
  1. Ozempic U.S. prescribing information (revised June 2026), DailyMed.
  2. Mounjaro U.S. prescribing information (revised July 2026), DailyMed.

Download Reko

Your record, in one private place

Two weeks free. Open every screen with an example record before you pay.

RekoTwo weeks freeDownload